The lymphatics revisited: New perspectives from the hyaluronan receptor LYVE-1

Trends in Cardiovascular Medicine

Volumn 13, Issue 1, 2003, Pages 1-7

  Jackson, David G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANTIGEN; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; CHEMOKINE; GROWTH FACTOR RECEPTOR; HYALURONIC ACID RECEPTOR; LYVE 1 RECEPTOR; MANNOSE RECEPTOR; PROTEIN ANTIBODY; RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; BASEMENT MEMBRANE; BLOOD VESSEL DIAMETER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOVASCULAR SYSTEM; CELL ISOLATION; CELL MIGRATION; CELL TYPE; CLINICAL RESEARCH; DEGRADATION; ENDOTHELIUM CELL; EXTRACELLULAR FLUID; GAP JUNCTION; HIGH RISK POPULATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LEUKOCYTE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TIGHT JUNCTION; TUMOR CELL;

EID: 0037238131     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00189-5     Document Type: Review

References (61)

1. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 1:2002;219-227.
2. Baekkevold E.S., Yamanaka T., Palframan R.T.et al. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med. 193:2001;1105-1111.
3. Bajorath J. Molecular organization structural features and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins. 39:2000;103-111.
4. Banerji S., Ni J., Wang S.-X.et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 144:1999;789-801.
5. Beasley N.J.P., Prevo R., Banerji S.et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62:2002;1315-1320.
6. Breiteneder-Geleff S., Matsui K., Soleiman A.et al. Podoplanin, a novel 43kD membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol. 151:1997;1141-1152.
7. Carreira C.M., Nasser S.M., di Tomaso E.et al. LYVE-1 is not restricted to the lymph vessels. expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis Cancer Res. 61:2001;8079-8084.
8. Clarijs R., Ruiter D.J., de Waal R.M. Lymphangiogenesis in malignant tumors. does it occur? J Pathol. 193:2001;143-146.
9. Cursiefen C., Schlotzer-Schrehardt U., Kuchle M.et al. Lymphatic vessels in vascularized human corneas. immunohistochemical evidence using LYVE-1 and podoplanin Invest Ophthalmol Vis Sci. 43:2002;2127-2135.
10. Cyster J. Chemokines and cell migration in secondary lymphoid organs. Science. 286:1999;2098-2102.
11. Day A.J. The structure and regulation of HA-binding proteins. Biochem Soc Trans. 27:1999;115-121.
12. Day A.J. Understanding hyaluronan-protein interactions. 2001;Glycoforum 16. Available at: http://www.glycoforum.gr.jp/science/hyaluronan/HA16/HA16E.html.
13. Engstrom-Laurent A. Changes in hyaluronan concentration in tissues and body fluids in disease states. CIBA Found Symp. 143:1989;233-247.
14. Estess P., DeGrendele H.C., Pascual V., Siegelman M.H. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J Clin Invest. 102:1998;1173-1182.
15. Fraser J.R., Laurent T.C. Turnover and metabolism of hyaluronan. CIBA Found Symp. 143:1989;41-53.
16. Gale N.W., Thurston G., Hackett S.F.et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell. 3:2002;411-423.
17. Grant A.J., Goddard S., Ahmed-Choudhury J.et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol. 160:2002;1445-1455.
18. Haak M.C., Bartelings M.M., Jackson D.G.et al. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod. 17:2002;1086-1092.
19. He Y., Kozaki K., Karpanen T.et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor-3 signalling. J Natl Cancer Inst. 94:2002;819-825.
20. Irjala H., Johansson E., Grenman R.et al. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med. 194:2001;1033-1042.
21. Jackson D.G. New markers for the study of lymphangiogenesis. Anticancer Res. 7:2001;1-5.
22. Jackson D.G., Prevo R., Clasper S., Banerji S. LYVE-1, the lymphatics and tumor lymphangiogenesis. Trends Immunol. 22:2001;317-321.
23. Jackson DG, Prevo R, Ni J, Banerji S: 2002. Novel endothelial hyaluronan receptors. In Kennedy JF, ed. Proceedings from "Hyaluronan 2000," Woodhead Publishing, Cambridge, UK.
24. Jail R.K., Fenton B.T. Intratumoral lymphatic vessels. a case of mistaken identity or malfunction? J Natl Cancer Inst. 94:2002;417-421.
25. Johnson P., Maiti A., Brown K.L., Li R. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem Pharmacol. 59:2000;455-465.
26. Jussila L., Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 82:2002;673-700.
27. Karkkainen M.J., Alitalo K. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Cell Dev Bio. 13:2002;9-18.
28. Karkkainen M.J., Jussila L., Ferrell R.E.et al. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends Mol Med. 7:2001;18-22.
29. Karkkainen M.J., Makinen T., Alitalo K. Lymphatic endothelium. a new frontier of metastasis research Nat Cell Biol. 4:2002;E2-E5.
30. Karpanen T., Egeblad M., Karkkainen M.J.et al. Vascular endothelial growth factor-C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61:2001;1786-1790.
31. Knudson C.B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J. 7:1993;1233-1241.
32. Kohda D., Morton C.J., Parkar A.A.et al. Solution structure of the link module. a hyaluronan binding domain involved in extracellular matrix stability and cell migration Cell. 86:1996;767-775.
33. Kriehuber E., Breiteneder-Geleff S., Groeger M.et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 194:2001;797-808.
34. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J. 6:1992;2397-2404.
35. Lee J.Y., Spicer A.P. Hyaluronan. a multifunctional, megaDalton, stealth molecule Curr Opin Cell Biol. 12:2000;581-586.
36. Leu A.J., Berk D.A., Lymboussaki A.et al. Absence of functional lymphatics within a murine sarcoma. a molecular and functional evaluation Cancer Res. 60:2000;4324-4327.
37. Liao H.-X., Levesque M.C., Patton K.et al. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol. 151:1993;6490-6499.
38. Maiti A., Maki G., Johnson P. TNF alpha induction of CD44-mediated leukocyte adhesion by sulfation. Science. 282:1998;941-943.
39. Makinen T., Veikkola T., Mustjoki S.et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:2001;4726-4773.
40. Mandriota S., Jussila L., Jeltsch M.et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J. 20:2001;672-682.
41. Mattila M.-T., Ruohola J.K., Karpanen T.et al. VEGF-C induced lymphangiogenesis and lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer. 98:2002;946-951.
42. Mohamadzadeh M., DeGrendele H., Arizpe H.et al. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest. 101:1998;97-108.
43. Nibbs R.J.B., Wylie S.M., Yang J.et al. Cloning and characterization of a novel promiscuous human beta chemokine receptor D6. J Biol Chem. 272:1997;32,78-32,83.
44. Noble P.W., McKee C.M., Cowman M., Shin H.S. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Clin Invest. 91:1996;2368-2377.
45. Oliver G., Detmar M. The rediscovery of the lymphatic system. old and new insights into the development and biological function of the lymphatic vasculature Genes Dev. 16:2002;773-783.
46. Orvidas L.J., Kasperbauer J.L. Pediatric lymphangiomas of the head and neck. Ann Otol Rhinol Laryngol. 109:2000;411-421.
47. Padera T.P., Kadambi A., Di Tomaso E.et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 296:2002;1883-1886.
48. Palframan R.T., Jung S., Cheng G.et al. Inflammatory chemokine transport and presentation in HEV. a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues J Exp Med. 194:2001;1361-1373.
49. Pepper M.S. Lymphangiogenesis and tumor metastasis. myth or reality? Clin Cancer Res. 7:2001;462-468.
50. Politz O., Gratchev A., McCourt P.et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J. 362:2002;155-164.
51. Prevo R., Banerji S., Ferguson D., Jackson D.G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem. 276:2001;19,420-19,430.
52. Skobe M., Hawighorst T., Jackson D.G.et al. Induction of tumor lymphangiogenesis by vascular endothelial growth factor-C promotes breast cancer metastasis. Nat Med. 7:2001;192-198.
53. Stacker S.A., Caesar C., Baldwin M.E.et al. Vascular endothelial growth factor-D promotes tumor growth and spread via the lymphatics. Nat Med. 7:2001;186-191.
54. Tammi R., Rilla K., Pienimaki J.P.et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem. 276:2001;35,111-35,122.
55. Termeer C.C., Hennies J., Voith U.et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol. 165:2000;1863-1870.
56. Weninger W., Partanen T.A., Breiteneder-Geleff S.et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest. 79:1999;243-251.
57. West D.C., Kumar S. Tumor-associated hyaluronan. a potential regulator of tumor angiogenesis Int J Radiat Biol. 60:1991;55-60.
58. Wigle J.T., Harvey N., Detmar M.et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21:2002;1505-1513.
59. Williams C.S.M., Leek R.D., Robson A.M.et al. Absence of intratumoral lymph vessels and lymphangiogenesis in human breast cancer. J Pathol. In press:2003.
60. Witte M.H., Bernas M.J., Martin C.P., Witte C.L. Lymphangiogenesis and lymphangiodysplasia. from molecular to clinical lymphology Microscopic Res Tech. 55:2001;122-145.
61. Zhou B., Weigel J.A., Fauss L., Weigel P.H. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem. 275:2000;37,733-37,741.